Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul;33(7):1211-1232.
doi: 10.1177/09622802241254197. Epub 2024 May 23.

Demystifying estimands in cluster-randomised trials

Affiliations

Demystifying estimands in cluster-randomised trials

Brennan C Kahan et al. Stat Methods Med Res. 2024 Jul.

Abstract

Estimands can help clarify the interpretation of treatment effects and ensure that estimators are aligned with the study's objectives. Cluster-randomised trials require additional attributes to be defined within the estimand compared to individually randomised trials, including whether treatment effects are marginal or cluster-specific, and whether they are participant- or cluster-average. In this paper, we provide formal definitions of estimands encompassing both these attributes using potential outcomes notation and describe differences between them. We then provide an overview of estimators for each estimand, describe their assumptions, and show consistency (i.e. asymptotically unbiased estimation) for a series of analyses based on cluster-level summaries. Then, through a re-analysis of a published cluster-randomised trial, we demonstrate that the choice of both estimand and estimator can affect interpretation. For instance, the estimated odds ratio ranged from 1.38 (p = 0.17) to 1.83 (p = 0.03) depending on the target estimand, and for some estimands, the choice of estimator affected the conclusions by leading to smaller treatment effect estimates. We conclude that careful specification of the estimand, along with an appropriate choice of estimator, is essential to ensuring that cluster-randomised trials address the right question.

Keywords: Estimand; analysis of cluster-level summaries; cluster-average; cluster-randomised trial; cluster-specific; independence estimating equations; marginal; participant-average.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interestsThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Difference between marginal participant- versus cluster-average odds ratio for ‘post-extubation stridor’ in the randomised evaluation of sedation titration for respiratory failure (RESTORE) trial. Each bubble denotes the proportion of events in that cluster. The size of the bubbles represents the weight given to each cluster, with hollow bubbles representing the participant-average weighting, and solid bubbles denoting the cluster-average weighting. The overall treatment group means are closer together under the cluster-average weighting than the participant-average weighting, owing to the cluster-average weighting giving more weight to smaller clusters with smaller between-group differences.

References

    1. ICH E9 (R1) addendum on estimands and sensitivity analysis in clinical trials to the guideline on statistical principles for clinical trials. https://www.ema.europa.eu/en/documents/scientific-guideline/ich-e9-r1-ad....
    1. Kahan BC, Cro S, Li Fet al. et al. Eliminating ambiguous treatment effects using estimands. Am J Epidemiol 2023; 192: 987–994. - PMC - PubMed
    1. Kahan BC, Hindley J, Edwards M, et al. The estimands framework: a primer on the ICH E9(R1) addendum. Br Med J 2024; 384: e076316. - PMC - PubMed
    1. Kahan BC, Li F, Copas AJet al. et al. Estimands in cluster-randomized trials: choosing analyses that answer the right question. Int J Epidemiol 2023;.52: 107–118. - PMC - PubMed
    1. Kahan BC, Morris TP, White IR, et al. Estimands in published protocols of randomised trials: urgent improvement needed. Trials 2021; 22: 686. - PMC - PubMed

MeSH terms

LinkOut - more resources